Journal of the American Chemical Society p. 1584 - 1594 (1995)
Update date:2022-08-04
Topics: Structures Syntheses Chromophores Reactivities Nickel(II)
Marganian, Christine A.
Vazir, Haresh
Baidya, Narayan
Olmstead, Marilyn M.
Mascharak, Pradip K.
The reaction of [Ni(terpy)Cl2] with ~2 equiv of 2,4,6-(Me)3C6H2Se- in 3:1 acetonitrile/ethanol affords [Ni(terpy)(2,4,6-(Me)3C6H2Se)2] (7), while [Ni(DAPA)Cl2] (DAPA = 2,6-bis[1-(phenylimino)ethyl]pyridine) reacts with ~2 equiv of PhS- and PhSe- in neat ethanol or acetonitrile to yield [Ni(DAPA)(SPh)2] (8) and [Ni(DAPA)-(SePh)2] (9), respectively. All three complexes contain the distorted trigonal bipyramidal (TBP) NiN3E2 (E = S, Se) chromophore. Previous X-ray absorption spectroscopic data have indicated a distorted TBP NiN3S2 coordination for the nickel site of the hydrogenase (H2ase) from Thiocapsa roseopersicina. Complex 7 crystallizes in the monoclinic space group P21/n with a = 13.170(6) ?, b = 16.091(5) ?, c = 15.111(8) ?, β = 114.42(2)°, V = 2916(2) A°3, and Z = 4. The structure of 7 was refined to R = 4.78% on the basis of 2730 reflections (I > 4σ(I)). Complex 8·CH3-CN crystallizes in the monoclinic space group P21/c with a = 23.012(7) ?, b = 17.814(5) ?, c = 15.698(4) ?, β = 108.52(2)°, V = 6099(5) ?3, and Z = 8. The structure of 8·CH3CN was refined to R = 6.46% on the basis of 6133 reflections (I > 4σ(I)). Complex 9·CH3CN also crystallizes in the monoclinic space group P21/c with a = 23.209(2) ?, b = 17.960(1) ?, c = 15.749(1) ?, β = 108.482(6)°, V = 6225 ?3, and Z = 8. The structure of 9·CH3CN was refined to 3.90% on the basis of 5808 reflections (I > 4σ(I)). Reduction of the terpy analogue 7 with aqueous dithionite gives rise to the corresponding Ni(I) complex which binds CO (reversibly) and H-. The EPR parameters of the CO and hydride adducts resemble the Ni-CO and Ni-C signal of the H2ases. Much like the other terpy analogues reported previously by this group, oxidation of 7 affords unstable Ni(III) products in low yields. The two DAPA analogues (8 and 9), on the other hand, are readily oxidized and reduced by biologically relevant oxidants and reductants, and the transformation Ni(III) ← Ni(II) → Ni(I) is reversible. The Ni(III) species (10 and 13) derived from 8 and 9 via oxidation with [Fe(CN)6]3- are comparatively stable and do not bind CO (or H-). The single electron in both 10 and 13 resides in the dz2 orbital. Upon reduction with aqueous dithionite, 8 and 9 produce the corresponding Ni(I) species 11 and 14 with the single electron in the dx2-y2 orbital. These Ni(I) complexes are quite stable at low temperatures but slowly lose thiolates/selenolates at room temperature to give [Ni(DAPA)(solv)2]+. Both 11 and 14 bind CO reversibly. The affinity of the Ni(I) (but not the Ni(III)) model complexes toward CO strongly suggests the presence of Ni(I) in the C form of the H2ases since the enzymes bind CO only in the Ni-C form. Reaction of NaBH4 with 8 and 9 results in the hydride adducts 19 and 20. These hydride adducts are stable under basic conditions. The absence of any detectable proton hyperfine coupling indicates that the H- ligand is located at the basal plane of the Ni(I) center. The EPR parameters of the CO and hydride adducts are quite similar to those of the Ni-CO and Ni-C signals of the H2ases. Under basic conditions, both 8 and 9 react with dihydrogen at ambient temperature and pressure to afford the hydride adducts 19 and 20 in significant yields. This reaction is quite remarkable since the model complexes mimic the reductive activation step of the biological nickel site in such a reaction to ultimately produce Ni-C-like signals. Taken together, the present results strongly suggest a Ni(I)-H- formalism for the nickel site in the C form of the H2ases. In addition, enhancement of the intensities of the EPR signals of the hydride adducts in the presence of a base indicates heterolytic cleavage of H2 (coordinated or not) at the Ni(I) site of the model complexes and probably also at the enzyme active sites.
View MoreContact:+86-913-2223392
Address:No. 32, Xinanjing Road, Weinan City, Shaanxi Province, 714000, China
Guangzhou Reachin Chemical Co., Ltd
Contact:+86-20-37087379 ext.604
Address:A122C-1, Tianyuan Plaza, 401 Tianyuan Rd., Tianhe, Guangzhou, China
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Contact:+86-158-05817090
Address:ROOM 9F, FLAT 2, GUODU DEVELOPING BLDG, No.182, ZHAOHUI ROAD
Yixing Zhenfen Medical Chemical Co.Ltd
Contact:86-510-87552708
Address:Fenshui ,Yixing city,Jiangsu
Doi:10.1021/jo00115a035
(1995)Doi:10.1016/j.bmc.2016.12.017
(2017)Doi:10.1039/c3ob42605j
(2014)Doi:10.1016/0957-4166(94)80058-8
(1994)Doi:10.1016/0022-328X(94)87167-1
(1994)Doi:10.1021/jo960131b
(1996)